# Metformin Versus Vildagliptin for Diabetic Hypertensive Patients

> **NCT03253562** · PHASE4 · COMPLETED · sponsor: **MTI University** · enrollment: 120 (actual)

## Conditions studied

- Reducing the Elevated Blood Pressure for Diabetic Hypertensive Patients

## Interventions

- **DRUG:** Metformin Pill
- **DRUG:** Vildagliptin 50 mg

## Key facts

- **NCT ID:** NCT03253562
- **Lead sponsor:** MTI University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-01
- **Primary completion:** 2017-08-01
- **Final completion:** 2017-08-01
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2017-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03253562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03253562, "Metformin Versus Vildagliptin for Diabetic Hypertensive Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03253562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*